Skip to main content

Table 1 Body weight, kidney weight, serum and urinary parameters in different groups after 8 weeks of treatment

From: Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress

  Normal Model AS-IV PBA
Body weight (g) 240.3 ± 14.3 225.6 ± 11.5 226.4 ± 8.4 230.7 ± 12.0*
Kidney weight (g) 1.4 ± 0.1 1.6 ± 0.4 1.4 ± 0.1* 1.4 ± 0.2*
Kidney/body weight ratio (%) 5.7 ± 0.5 7.1 ± 1.0 6.3 ± 0.4* 6.2 ± 0.5*
SCr (μmol/L) 25.5 ± 10.8 51.0 ± 11.5 33.4 ± 8.7* 27.6 ± 6.9*
BUN (mmol/L) 15.4 ± 3.9 53.8 ± 11.8 26.1 ± 2.3* 25.4 ± 2.5*
Urinary albumin excretion (μg/day) 571.7 ± 72.4 1510.0 ± 392.7 799.4 ± 121.5* 757.9 ± 105.5*
Blood glucose (mmol/L) 8. 5 ± 0.9 21.9 ± 5.4 19.8 ± 1.2 12.3 ± 4.9*
  1. Data are presented as the mean ± SD. P < 0.05 vs Normal, *P < 0.05 vs Model.